Thompson Street Capital Partners acquires Lifespan Biosciences
Private equity firm Thompson Street Capital Partners (TSCP) has partnered with management to acquire Seattle-based LifeSpan Biosciences (LSBio), a founder-led developer and distributer of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. Terms of the transaction have not been disclosed. LSBio,
